CVSG.F Stock Overview

Engages in veterinary, pet crematoria, online pharmacy, and retail businesses. More details

CVSG.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	2/6
Financial Health	4/6
Dividends	3/6

Rewards

Trading at 55.3% below our estimate of its fair value

Earnings are forecast to grow 15.48% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Profit margins (4%) are lower than last year (8.2%)

My Notes

Capture your thoughts, links and company narrative

CVS Group plc Competitors

U.S. Physical Therapy

NYSE:USPH

US$1.4b

National HealthCare

NYSEAM:NHC

US$1.7b

Ardent Health Partners

NYSE:ARDT

US$2.3b

PACS Group

NYSE:PACS

US$2.0b

Price History & Performance

Summary of share price highs, lows and changes for CVS Group
Historical stock prices
Current Share Price	UK£11.00
52 Week High	UK£19.94
52 Week Low	UK£11.00
Beta	1.07
1 Month Change	-7.11%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-20.00%

Recent updates

Shareholder Returns

	CVSG.F	US Healthcare	US Market
7D	0%	3.3%	2.8%
1Y	n/a	-9.1%	24.6%

Return vs Industry: Insufficient data to determine how CVSG.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how CVSG.F performed against the US Market.

Price Volatility

Is CVSG.F's price volatile compared to industry and market?
CVSG.F volatility
CVSG.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.4%
10% least volatile stocks in US Market	3.1%

Stable Share Price: CVSG.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine CVSG.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	8,822	Richard William Fairman	www.cvsukltd.co.uk

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

CVS Group plc Fundamentals Summary

How do CVS Group's earnings and revenue compare to its market cap?
CVSG.F fundamental statistics
Market cap	US$743.80m
Earnings (TTM)	US$32.89m
Revenue (TTM)	US$812.50m

22.6x

P/E Ratio

0.9x

P/S Ratio

Is CVSG.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVSG.F income statement (TTM)
Revenue	UK£647.30m
Cost of Revenue	UK£369.40m
Gross Profit	UK£277.90m
Other Expenses	UK£251.70m
Earnings	UK£26.20m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 27, 2025

Earnings per share (EPS)	0.37
Gross Margin	42.93%
Net Profit Margin	4.05%
Debt/Equity Ratio	69.6%

How did CVSG.F perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

22%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 18:39
End of Day Share Price	2024/12/18 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CVS Group plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Bayliss	Berenberg
Robert Chantry	Berenberg
Conall MacCoille	Davy